Vivimed Labs Beheer
Beheer criteriumcontroles 3/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Santosh Varalwar
Algemeen directeur
₹12.0m
Totale compensatie
| Percentage CEO-salaris | 100.0% |
| Dienstverband CEO | 33.9yrs |
| Eigendom CEO | 1.6% |
| Management gemiddelde ambtstermijn | 4.6yrs |
| Gemiddelde ambtstermijn bestuur | 22.3yrs |
Recente managementupdates
Recent updates
Is Vivimed Labs (NSE:VIVIMEDLAB) Weighed On By Its Debt Load?
Mar 30
Is Vivimed Labs (NSE:VIVIMEDLAB) Using Too Much Debt?
Dec 14Estimating The Intrinsic Value Of Vivimed Labs Limited (NSE:VIVIMEDLAB)
Jun 30Estimating The Intrinsic Value Of Vivimed Labs Limited (NSE:VIVIMEDLAB)
Feb 22Did Vivimed Labs Limited (NSE:VIVIMEDLAB) Insiders Buy Up More Shares?
Jan 19Is Vivimed Labs (NSE:VIVIMEDLAB) Using Too Much Debt?
Nov 25
Are Insiders Buying Vivimed Labs Limited (NSE:VIVIMEDLAB) Stock?
Sep 22Is Vivimed Labs (NSE:VIVIMEDLAB) Using Debt In A Risky Way?
Jul 31Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | -₹3b |
| Mar 31 2023 | ₹12m | ₹12m | -₹3b |
| Dec 31 2022 | n/a | n/a | -₹809m |
| Sep 30 2022 | n/a | n/a | -₹862m |
| Jun 30 2022 | n/a | n/a | -₹875m |
| Mar 31 2022 | ₹12m | ₹12m | -₹676m |
| Dec 31 2021 | n/a | n/a | -₹768m |
| Sep 30 2021 | n/a | n/a | -₹1b |
| Jun 30 2021 | n/a | n/a | -₹930m |
| Mar 31 2021 | ₹10m | ₹10m | -₹719m |
| Dec 31 2020 | n/a | n/a | -₹1b |
| Sep 30 2020 | n/a | n/a | -₹937m |
| Jun 30 2020 | n/a | n/a | -₹1b |
| Mar 31 2020 | ₹6m | ₹6m | -₹1b |
| Dec 31 2019 | n/a | n/a | -₹485m |
| Sep 30 2019 | n/a | n/a | -₹56m |
| Jun 30 2019 | n/a | n/a | ₹391m |
| Mar 31 2019 | ₹6m | ₹6m | ₹574m |
| Dec 31 2018 | n/a | n/a | ₹686m |
| Sep 30 2018 | n/a | n/a | ₹787m |
| Jun 30 2018 | n/a | n/a | ₹825m |
| Mar 31 2018 | ₹6m | ₹6m | ₹779m |
| Dec 31 2017 | n/a | n/a | ₹2b |
| Sep 30 2017 | n/a | n/a | ₹2b |
| Jun 30 2017 | n/a | n/a | ₹2b |
| Mar 31 2017 | ₹6m | ₹6m | ₹2b |
Compensatie versus markt: De totale vergoeding ($USD 143.97K ) Santosh } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Indian markt ($USD 42.67K ).
Compensatie versus inkomsten: De vergoeding van Santosh is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Santosh Varalwar (61 yo)
33.9yrs
Tenure
₹12,000,000
Compensatie
Mr. Santosh Varalwar has been the Managing Director of Vivimed Labs Limited since January 27, 2004 and has been its Executive Director since November 09, 1989. Mr. Varalwar served as Chief Executive Office...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| MD & Executive Director | no data | ₹12.00m | 1.57% ₹ 6.4m | |
| Chief Financial Officer | 1.5yrs | ₹6.00m | geen gegevens | |
| Compliance Officer & Company Secretary | no data | ₹3.06m | geen gegevens | |
| Whole Time Director | 4.6yrs | ₹3.00m | 1.25% ₹ 5.1m | |
| Executive Director | no data | ₹10.00m | 2.26% ₹ 9.3m | |
| Chief Executive of Uquifa - Vivimed’s API Division | 33.8yrs | geen gegevens | geen gegevens |
4.6yrs
Gemiddelde duur
61yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van VIVIMEDLAB wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.6 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| MD & Executive Director | 33.9yrs | ₹12.00m | 1.57% ₹ 6.4m | |
| Whole Time Director | 28.9yrs | ₹3.00m | 1.25% ₹ 5.1m | |
| Executive Director | 15.8yrs | ₹10.00m | 2.26% ₹ 9.3m | |
| Non-Executive Promoter Director | 33.9yrs | ₹175.00k | 1.95% ₹ 8.0m | |
| Independent Chairman & Lead Independent Director | 3.7yrs | ₹375.00k | geen gegevens | |
| Non-Executive Independent Woman Director | 1.7yrs | ₹375.00k | geen gegevens |
22.3yrs
Gemiddelde duur
68yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van VIVIMEDLAB zijn ervaren en ervaren (gemiddelde ambtstermijn van 22.3 jaar).